Phase I study of peptide receptor radionuclide therapy with [111In-DTPA0]octreotide: The rotterdam experienceRoelf Valkema, Eric P. Krenning, P.P.M. Kooij et al.|Seminars in Nuclear Medicine|2002Cited by 433
Somatostatin receptor-targeted radionuclide therapy of tumors: Preclinical and clinical findingsMarion de Jong, Eric P. Krenning, Roelf Valkema et al.|Seminars in Nuclear Medicine|2002Cited by 347